abrdn Life Sciences Investors SEC filings HQL

abrdn Life Sciences Investors has 519 filings in SEC EDGAR's recent list, going back to Dec 13, 1995. The most recent current report (Form 8-K) was filed on Sep 12, 2023 (auditor change). The company's fiscal year ends on September 30.

abrdn Life Sciences Investors SEC filings
Form Description Filed Period
8-K Current report
Auditor change
Sep 12, 2023 Sep 6, 2023
8-K Current report
Other events
Mar 25, 2013 Mar 22, 2013
8-K Current report
Other events
Mar 23, 2012 Mar 23, 2012
8-K Current report
Other events
Jun 30, 2011 Jun 30, 2011
8-K Current report
Other events
May 3, 2011 May 2, 2011
8-K Current report
Other events
Nov 2, 2010 Nov 1, 2010
8-K Current report
Other events
Apr 6, 2010 Apr 5, 2010
8-K Current report
Other events
Sep 30, 2009 Sep 30, 2009
8-K Current report
Other events
Aug 4, 2009 Aug 4, 2009
8-K Current report
Other events
Jul 18, 2008 Jul 18, 2008

Showing 10 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Listed as
HQL (NYSE)
Fiscal year ends
September 30
Incorporated in
MA
Headquarters
Philadelphia, PA
SEC CIK
884121
Former names
TEKLA LIFE SCIENCES INVESTORS (until Oct 5, 2023); H&Q LIFE SCIENCES INVESTORS (until Sep 18, 2014)

Source: SEC EDGAR filings. This is company-reported data, not investment advice.